Health Condition 1: J984- Other disorders of lung
Conditions
Interventions
None listed
Sponsors
Cipla Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children and adult male or female patients within 12 to 60 years of age 2. Physician diagnosed asthma according to GINA guidelines and documented airflow limitation 3. Treatment naïve as well as patients on treatment 4. Able to comply with study requirement in the opinion of the investigator
Exclusion criteria
Exclusion criteria: 1. Patients who have participated in interventional clinical study in the last 2 months 2. Patients who are contraindicated from performing spirometry based on a recent surgery history. 3. Patients with documented history of idiopathic haemoptysis, active lung infection any syncope associated with forced exhalation 4. Abnormal baseline findings considered by Investigator to indicate conditions that might affect study endpoints 5. Patients with acute infection being treated with intravenous antibiotics. 6. Any other condition that, in the investigator judgment, might increase the risk to the patient or decrease the chance of obtaining satisfactory information needed to achieve the objectives of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To estimate the prevalence of small airways dysfunction across all severities of asthma using IOSTimepoint: IOS compared to Spirometry. Single visit study | — |
Secondary
| Measure | Time frame |
|---|---|
| To correlate various IOS parameter with spirometry parameter pre and post administration of the bronchodilator To correlate various IOS parameters with level of asthma control measured by ACQ 5 This is an observational study to understand prevalence of asthma using IOSTimepoint: IOS compared to Spirometry. This is a single visit study | — |
Countries
India
Contacts
Public ContactDr Ambar Vaidya
PhaseON Clinical Research Pvt. Ltd.
Outcome results
None listed